logo
What Causes Anemia?

What Causes Anemia?

Health Line5 hours ago
Anemia may develop from having too few red blood cells or too little hemoglobin, the iron-rich protein that carries oxygen to all of your organs.
Anemia is a signal that your body's capacity to transport oxygen to every organ has been compromised. This can cause unsettling symptoms like fatigue and breathlessness.
Anemia can result from multiple and overlapping disruptions to your body's natural cycles and processes, especially in the making, carrying, and recycling of red blood cells.
Acute anemia often results from unexpected or rapid blood loss. Chronic forms of anemia may develop gradually and have multiple causes.
Common causes of anemia
The most common causes of chronic anemia include:
Your body isn't making enough red blood cells
Your body needs certain nutrients — especially iron, vitamin B12, and folate — to build healthy red blood cells. If you don't get enough of these nutrients, or if your body can't use them properly, red blood cell production slows down.
Iron deficiency
The most common cause of anemia is not having enough iron in your body. This can happen if you're not eating enough iron-rich foods, or if your body has trouble absorbing or holding on to the iron you do eat.
When there isn't enough iron in the blood, your body cannot make enough hemoglobin. This protein in red blood cells carries oxygen.
As a result, your red blood cells may be smaller and lighter in color than usual, and some organs that need oxygen the most, like your brain and heart, may not be able to work as expected.
Causes of iron deficiency anemia may include:
Vitamin B deficiency
Your body also needs vitamin B12 and folate (a type of vitamin B) to make red blood cells. Without these vitamins, the bone marrow creates cells that are too large and don't work properly.
Vitamin B12 deficiency anemia, also known as megaloblastic anemia, can cause symptoms like fatigue and weakness. It may also manifest with hand or foot numbness or memory challenges.
Causes of vitamin B deficiency may include:
not eating enough animal products
living with digestive conditions where the body can't absorb vitamin B12
taking certain medications that interfere with nutrient absorption
being pregnant
having digestive diseases that affect folate levels
Your body is losing blood
Another common cause of anemia is that the body loses red blood cells faster than it can create new ones. This can result from a single event (like surgery or an accident) or slowly over time. It is related to the above cause of nutrient deficiency.
The most common causes of blood loss that lead to anemia include:
heavy menstrual periods
stomach or intestinal bleeding
internal bleeding from injuries or surgery
bleeding disorders, like hemophilia or persistent nosebleeds
frequent blood donations without giving your body time to catch up
Your body is destroying red blood cells too early
Red blood cells usually live for 120 days. After that, your body replaces them. But sometimes, the immune system or living with specific conditions may lead your body to destroy red blood cells when they are still young.
When this happens, your body may not have time to make enough new red blood cells, and this can lead to a type of anemia known as hemolytic anemia.
Hemolytic anemia isn't as common as nutrient deficiency anemia, but it may become more serious.
Common causes of hemolytic anemia may include:
autoimmune conditions in which the body attacks its own red blood cells
systemic infections
inherited conditions, like sickle cell disease or thalassemia
toxin poisoning
side effects of medications
»Learn more: How to increase red blood cell count
Your body is fighting a long-term condition
Some health conditions may make it harder for your body to produce healthy red blood cells.
Anemia of chronic disease or anemia of inflammation is common in people with:
kidney disease
cancer
diabetes
HIV
rheumatoid arthritis
lupus
Chronic inflammation makes your liver produce a hormone called hepcidin, which interferes with your body's ability to move stored iron into the bloodstream. Your iron reserves live mostly in the liver. So, when your liver doesn't release enough iron, your red blood cell production decreases, even if you are not low in iron.
This type of anemia may develop gradually and not cause evident symptoms at first.
Your bone marrow isn't working properly
Red blood cells are made in the bone marrow (tissue inside your bones). Problems with the marrow mean your body can't produce as many red blood cells as it needs. This is a rare but serious occurrence.
Conditions that may affect the health of your bone marrow include:
myelodysplastic syndromes, where the bone marrow produces cells that don't work well
blood cancers, like leukemia
cancer therapy, like chemotherapy and radiation therapy
What increases your chances of anemia?
Anyone can develop anemia, but some people may have a higher chance of developing it based on their health, age, sex, and lifestyle.
You may be at a higher risk of anemia if you:
menstruate, and especially if your periods are heavy and prolonged
are pregnant, because your body needs more iron and vitamins to support your baby's development
are still developing mentally and physically, because the body needs more nutrients during childhood and adolescence
are an older adult, especially over the age 65, because nutrient absorption is more likely to be compromised
are vegan or vegetarian
have had surgery, especially stomach or intestinal procedures
live with a chronic disease
take medications, like acid reducers, chemotherapy, or seizure drugs
have a family or personal history of blood disorders
have intestinal parasites
have had major blood loss
Takeaway
The main causes of anemia include nutrient deficiency (mostly iron and vitamin B) and impaired red blood cell production.
Anemia responds to treatment, and the first step to management is identifying the root cause. A healthcare professional may want to gather more information about your medical history and perform tests, like bloodwork.
If you experience persistent symptoms like unexplained fatigue, dizziness, shortness of breath, and heart palpitations, consider seeking medical care for testing. A primary care physician can help with the first steps.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims
Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims

Yahoo

time18 minutes ago

  • Yahoo

Why is GDRX stock up 30% today? GoodRx strikes deal to sell Ozempic and Wegovy after Novo Nordisk's breakup with Hims

Share prices of GoodRx (NASDAQ: GDRX), the American healthcare company and telemedicine service, are currently soaring after the company announced that it will partner with Novo Nordisk to offer the lowest-ever out-of-pocket prices for Ozempic and Wegovy. Unsold completed new-build inventory is so high this $34B homebuilder is turning to investors 'Job hugging' is the newest career trend: Here's what it means—and why Gen Z is into it Spotify just redesigned the way you'll 'listen' to audiobooks According to a press release posted early on August 18, GoodRx has struck a deal with the pharmaceutical giant Novo Nordisk to sell its popular semaglutide medications, Ozempic and Wegovy, for just $499 per month to 'eligible self-paying customers.' GoodRx doesn't sell or dispense any drugs itself, but rather provides savings and coupons that can be applied in pharmacies. Its exclusive Ozempic and Wegovy offerings, available starting today, are the lowest out-of-pocket costs for the medications available on the market. The news comes just weeks after Novo Nordisk cut ties with the telehealth company Hims & Hers Health (NYSE: HIMS) over claims that Hims & Hers was selling 'knockoff' versions of Wegovy. It's a dispute that reflects a broader discussion around whether compounded semaglutide drugs—or non-FDA approved versions of brand-name medicines—are a violation of intellectual property laws. As of this writing, GoodRx's stock is up by more than 30% since market close. Here's what to know about Novo Nordisk's latest partnership and its ongoing legal battles against compounded GLP-1s. GoodRx's collaboration with Novo Nordisk In the last year alone, GoodRx reports that nearly 17 million people visited the site searching for information and savings on GLP-1 medications—a 22% increase from the previous year. 'Demand for GLP-1 medications is at an all-time high, but too many Americans still face barriers accessing them,' Wendy Barnes, GoodRX president and CEO, said in the press release. 'By partnering with Novo Nordisk, we're taking a significant step forward in making these innovative brand-name treatments more accessible for millions of people who need them.' In the past, a spokesperson told Fast Company, GoodRx has worked with both Novo Nordisk and its competitor Eli Lilly to offer commercially insured patients manufacturer savings cards on GLP-1s. The company has also offered savings on other types of weight loss/diabetes treatments, including Contrave, Dexcom G7, Lantus, and Qsymia. However, this is the first time that GoodRx has offered a cash price for a GLP-1. The $499 monthly self-pay cost will be available at more than 70,000 retail locations nationwide. Novo Nordisk's current legal battles over compounded GLP-1s So far, investors' response to GoodRx's new collaboration has been overwhelmingly positive. It stands in sharp contrast to Hims & Hers' recent breakup with Novo Nordisk, which caused the telehealth company's share prices to plummet in late June. Hims & Hers and Novo Nordisk parted ways over Hims & Hers' offering of compounded versions of Wegovy. Back in 2022, the Food and Drug Administration (FDA) declared a shortage of GLP-1 medications including Ozempic and Wegovy. Under this shortage notice, pharmacies were permitted to make compounded versions of the brand-name drugs using their active ingredient, semaglutide, and sell them at a lower cost. However, Hims & Hers has continued to sell its compounded version of Wegovy long after the FDA lifted the shortage back in February. Now, Novo Nordisk is arguing that these compounded drugs are both a violation of its intellectual property and potentially dangerous to patients, due to their lack of FDA approval. Early this month, Novo Nordisk announced 14 new lawsuits against small pharmacies, telehealth providers, and weight-loss clinics over compounded versions of Ozempic and Wegovy—bringing its total cases filed on the matter up to more than 130 in 40 states. Experts say that federal compounding laws are just vague enough to allow for various interpretations, meaning that Novo Nordisk's current legal challenges could shape the way courts interpret those boundaries in the future. In a statement to Yahoo Finance, Barnes offered a clear look into GoodRx's stance on compounded drugs: 'There's no question we could have tried to do something sooner from a compounded alternative pathway, but we have been very clear in our belief that it needed to be FDA-approved, lawfully approved. It just wasn't a pathway that we were going to support,' she said. This post originally appeared at to get the Fast Company newsletter:

RFK Jr. attacks pediatricians' group over vaccine recommendations
RFK Jr. attacks pediatricians' group over vaccine recommendations

Yahoo

time39 minutes ago

  • Yahoo

RFK Jr. attacks pediatricians' group over vaccine recommendations

The gloves are off in Robert F. Kennedy Jr.'s feud with American doctors. Hours after the American Academy of Pediatrics, the professional society for doctors who care for children, issued Covid-19 vaccine guidance contradicting that of the health secretary, Kennedy accused the group of engaging in a 'pay-to-play scheme to promote commercial ambitions of AAP's Big Pharma benefactors' in a post on social media platform X. Kennedy cited donations from Covid mRNA vaccine drugmakers Pfizer and Moderna, among other pharmaceutical companies, to the pediatricians' Friends of Children Fund, which backs projects promoting children's health and health equity. Kennedy said the contributions constituted a conflict of interest and suggested they led to the group's decision to recommend that young children, between 6 and 23 months old, receive Covid vaccines. In May, the Centers for Disease Control and Prevention dropped its recommendation that all children 6 months and older get Covid shots. Kennedy at the time said the move was based on 'common sense' and 'good science.' The AAP, however, said it had retained its guidance for young children to get the shots because they are still at risk of severe cases of the disease. 'COVID-19 continues to result in hospitalization and death in the pediatric population,' the group said in a release explaining its recommendations, adding that 'children younger than 2 years old are especially vulnerable to severe COVID-19 and should be prioritized for vaccination.' The pediatric group did not immediately respond to POLITICO's request for comment regarding Kennedy's remarks. Earlier Tuesday, HHS spokesperson Andrew Nixon accused the pediatricians of 'freelancing its own recommendations, while smearing those who demand accountability' in a statement to POLITICO. AAP President Susan J. Kressly defended her group's guidance in response, saying they were 'based only in the science, the needs of children, and the care that pediatricians have for the children in every community.' Despite the disagreement over vaccination of young children, both the new CDC guidance and the pediatricians continue to recommend shots for children with underlying conditions that could put them at risk for severe disease. Both have also scaled back recommendations for healthy children older than 6 months, saying that parents of children without underlying conditions should decide on vaccination in consultation with their pediatrician. Why it matters: The pediatricians' split with the CDC underscores the depth of the distrust between the medical establishment and Kennedy — a longtime vaccine skeptic who once said the Covid vaccine was 'the deadliest vaccine ever made' in defiance of scientific consensus. Before Kennedy's arrival, the agency and the pediatricians agreed on vaccine recommendations, but Kennedy's efforts to overhaul federal vaccine policy have upset the relationship. Earlier this summer, he ousted all the members of the expert panel that advises the CDC on vaccines, the Advisory Committee on Immunization Practices, tapping new members with a history of vaccine skepticism. Most recently, Kennedy rescinded $500 million earmarked for research into mRNA technology, which was used to develop the Moderna and Pfizer Covid vaccines. And his latest post isn't the first time he's criticized doctors. The May report from his Make America Health Again Commission assessing the causes of chronic disease in children was laced with accusations that doctors are influenced by the pharmaceutical industry to overprescribe certain medications and fail to treat the root causes of disease. The split also comes as children return to school and the annual fall vaccination campaign for Covid and the flu is beginning. Kennedy suggested that the pediatric group could be exposing its member doctors to liability in his X post, stating that 'AAP should also be candid with doctors and hospitals that recommendations that diverge from the CDC's official list are not shielded from liability under the 1986 Vaccine Injury Act.' The National Vaccine Injury Compensation Program, which that law created, doesn't cover Covid vaccines, but Kennedy has said he wants to overhaul the system for compensating people who experience serious side effects from vaccines. He would likely need Congress' assent to change it.

NASA and Google are testing an AI space doctor
NASA and Google are testing an AI space doctor

Digital Trends

time41 minutes ago

  • Digital Trends

NASA and Google are testing an AI space doctor

With NASA eyeing long-duration crewed missions to the moon and beyond in the coming years, it has to be sure that if a medical situation arises, the astronauts are well equipped to deal with it. Currently, crews heading to the International Space Station (ISS) receive training for basic medical procedures and medicines, as well as for things like intravenous fluid administration, intubation, wound care, and basic emergency response. Recommended Videos But future missions that take humans hundreds of thousands — or even millions — of miles from Earth, potentially for years at a time, will add a new layer of complexity to health management. With that in mind, the U.S. space agency has partnered with Google on a project aimed at ensuring crew health and wellness on long-duration missions. The initiative includes an investigation into whether remote care capabilities can offer detailed diagnoses and treatment options when a health issue falls outside of the astronauts' knowledge base, and when real-time communication with Earth is limited. NASA and Google's work involves a proof-of-concept for an automated Clinical Decision Support System (CDSS) known as the 'Crew Medical Officer Digital Assistant' (CMO-DA). 'Designed to assist astronauts with medical help during extended space missions, this multi-modal interface leverages AI,' Google said in an online post. It said the CMO-DA tool could help astronauts 'autonomously diagnose and treat symptoms when crews are not in direct contact with Earth-based medical experts.' It added: 'Trained on spaceflight literature, the AI system uses cutting-edge natural language processing and machine learning techniques to safely provide real-time analyses of crew health and performance. The tool is designed to support a designated crew medical officer or flight surgeon in maintaining crew health and making medical decisions driven by data and predictive analytics.' Early results from initial trials have 'showed promise' for obtaining reliable diagnoses based on reported symptoms. Moving forward, NASA and Google are now working with medical doctors to improve the technology with a view to using it on future space missions. As part of NASA's Artemis program, astronauts could one stay for extended periods aboard a lunar satellite — similar to how they live and work aboard the ISS today — or even on the moon itself. More ambitious endeavors, such as to Mars, are also on the cards, but aren't expected to take place until the 2030s at the earliest.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store